Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antiphospholipid Syndrome | 5 | 2021 | 165 | 1.800 |
Why?
|
| Polypharmacy | 2 | 2021 | 306 | 1.200 |
Why?
|
| Antibodies, Antiphospholipid | 3 | 2021 | 71 | 0.710 |
Why?
|
| Coronary Stenosis | 1 | 2023 | 802 | 0.580 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 842 | 0.460 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1535 | 0.400 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2021 | 2157 | 0.340 |
Why?
|
| Heart Failure | 4 | 2023 | 11701 | 0.340 |
Why?
|
| Endoscopy | 2 | 2015 | 1852 | 0.310 |
Why?
|
| Lymphocytes | 1 | 2016 | 2603 | 0.310 |
Why?
|
| Mitral Valve | 1 | 2016 | 1465 | 0.290 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 991 | 0.250 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6504 | 0.220 |
Why?
|
| Neutrophils | 1 | 2016 | 3763 | 0.220 |
Why?
|
| Intestinal Perforation | 2 | 2015 | 249 | 0.210 |
Why?
|
| Databases, Factual | 1 | 2019 | 7969 | 0.210 |
Why?
|
| Breast Neoplasms | 4 | 2017 | 20981 | 0.200 |
Why?
|
| Thrombosis | 1 | 2016 | 2944 | 0.200 |
Why?
|
| Hospitalization | 2 | 2023 | 10712 | 0.190 |
Why?
|
| Phenotype | 1 | 2019 | 16572 | 0.180 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2021 | 147 | 0.170 |
Why?
|
| Stroke | 2 | 2019 | 9720 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2023 | 15308 | 0.130 |
Why?
|
| Catastrophic Illness | 1 | 2017 | 60 | 0.130 |
Why?
|
| Embolism | 1 | 2019 | 399 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2017 | 159 | 0.130 |
Why?
|
| Stomach Rupture | 1 | 2015 | 2 | 0.130 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2017 | 136 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 2254 | 0.130 |
Why?
|
| Duodenum | 2 | 2015 | 491 | 0.120 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 65 | 0.120 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2015 | 56 | 0.120 |
Why?
|
| Drug Utilization | 1 | 2020 | 1188 | 0.120 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 781 | 0.120 |
Why?
|
| Serologic Tests | 1 | 2016 | 381 | 0.110 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2015 | 86 | 0.110 |
Why?
|
| Menarche | 1 | 2017 | 532 | 0.110 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 172 | 0.110 |
Why?
|
| Obesity | 1 | 2015 | 12937 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1000 | 0.110 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 426 | 0.100 |
Why?
|
| Surgical Instruments | 1 | 2015 | 383 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2023 | 3111 | 0.100 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 508 | 0.100 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 2913 | 0.100 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 539 | 0.100 |
Why?
|
| Age Factors | 2 | 2020 | 18385 | 0.100 |
Why?
|
| Coronary Angiography | 1 | 2023 | 4506 | 0.100 |
Why?
|
| Anticoagulants | 4 | 2022 | 4795 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1669 | 0.090 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 5115 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6305 | 0.090 |
Why?
|
| Humans | 22 | 2023 | 761098 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2023 | 2513 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 1086 | 0.090 |
Why?
|
| Sirolimus | 1 | 2017 | 1540 | 0.080 |
Why?
|
| Neutropenia | 1 | 2015 | 885 | 0.080 |
Why?
|
| Cardiology | 1 | 2020 | 1693 | 0.080 |
Why?
|
| Brain | 1 | 2016 | 27097 | 0.080 |
Why?
|
| Aged | 7 | 2023 | 169266 | 0.080 |
Why?
|
| Menopause | 1 | 2017 | 1646 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1868 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2023 | 58946 | 0.080 |
Why?
|
| Risk Factors | 4 | 2020 | 74219 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3422 | 0.070 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 1366 | 0.070 |
Why?
|
| Female | 13 | 2023 | 392458 | 0.070 |
Why?
|
| Comorbidity | 1 | 2020 | 10514 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3821 | 0.060 |
Why?
|
| Adult | 7 | 2019 | 221083 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 2746 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4189 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10083 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8456 | 0.050 |
Why?
|
| Echocardiography | 1 | 2016 | 5006 | 0.050 |
Why?
|
| Middle Aged | 7 | 2023 | 220835 | 0.050 |
Why?
|
| Registries | 1 | 2019 | 8236 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2022 | 24013 | 0.050 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2021 | 32 | 0.050 |
Why?
|
| Warfarin | 2 | 2020 | 1482 | 0.050 |
Why?
|
| Inflammation | 1 | 2017 | 10758 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 29872 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 329 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2017 | 235 | 0.030 |
Why?
|
| Male | 5 | 2023 | 360675 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 54419 | 0.030 |
Why?
|
| American Heart Association | 1 | 2020 | 1043 | 0.030 |
Why?
|
| United States | 2 | 2020 | 72337 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7240 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 39953 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2016 | 524 | 0.030 |
Why?
|
| Ferritins | 1 | 2017 | 597 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 41486 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 80673 | 0.020 |
Why?
|
| Rectum | 1 | 2015 | 891 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3899 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4014 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2023 | 5520 | 0.020 |
Why?
|
| Emergencies | 1 | 2015 | 1217 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2510 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36418 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 3269 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3881 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2208 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 2478 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4908 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2928 | 0.020 |
Why?
|
| Prognosis | 2 | 2017 | 29672 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 64670 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2553 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3461 | 0.010 |
Why?
|
| Biopsy | 1 | 2016 | 6781 | 0.010 |
Why?
|
| Risk | 1 | 2016 | 9614 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 21357 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11118 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20600 | 0.010 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_